Results 211 to 220 of about 15,268,350 (380)

Correction: K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity. [PDF]

J Biomed Sci
Zeng Q, Guo H, Tang N, Renavikar PS, Karandikar NJ, Lovett-Racke AE, Racke MK, Yan C, Tang R, Sinha S, Ghosh K, Ryal JP, Ouyang S, Chen M, Amari F, Vincenzo C, Pope RM, Li Y, Yang H, Langdon WY, Zhang J.   +20 more
europepmc   +1 more source

The State of Medicine [PDF]

Postgraduate Medical Journal, 1982
openaire   +2 more sources

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Unusual Presentation of Epidermodysplasia Verruciformis (EV) in Non-Sun Exposed Area: A Case Report. [PDF]

Case Rep Dermatol Med
Jebrini N, Dwaik M, Jaber M, Jabari S, Razem R, Sarahna M, Alzaro R, Aljabari F, Aqel M, Sarahneh H.   +9 more
europepmc   +1 more source

Államorvostan a felvilágosodás kori Magyarországon Enlightenment State Medicine in Hungary

Kaleidoscope History, 2010
Schultheisz Emil Prof. em. Dr.
doaj  

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Author Correction: Thermo-responsive triple-function nanotransporter for efficient chemo-photothermal therapy of multidrug-resistant bacterial infection. [PDF]

Nat Commun
Qing G, Zhao X, Gong N, Chen J, Li X, Gan Y, Wang Y, Zhang Z, Zhang Y, Guo W, Luo Y, Liang XJ.   +11 more
europepmc   +1 more source

Observations on the Fine Structure of the Fibroblast from a Case of Ehlers-Danlos Syndrome with the Marfan Syndrome**From the Laboratory of Cellular Pathology, the Departments of Pathology and Medicine, The Ohio State University College of Medicine, Columbus, Ohio.

, 1968
Dante G. Scarpelli, Richard M. Goodman
openalex   +1 more source

Points from Letters: Present State of Medicine [PDF]

, 1964
J. F. Santer
openalex   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source